(Q39698447)

14 September 2017

title

Imatinib and docetaxel in combination can effectively inhibit glioma invasion in an in vitro 3D invasion assay (English)

1 reference

14 September 2017

1 reference

1 reference

Paula Kinsella

1

1 reference

14 September 2017

Martin Clynes

series ordinal

2

1 reference

14 September 2017

Verena Amberger-Murphy

series ordinal

3

1 reference

14 September 2017

publication date

30 May 2010

1 reference

Journal of Neuro-Oncology

14 September 2017

published in

1 reference

14 September 2017

volume

101

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

189-198

1 reference

The WHO classification of tumors of the nervous system

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0246-1

Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0246-1

Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0246-1

Treatment options for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0246-1

Cell signaling by receptor tyrosine kinases

21 January 2018

1 reference

12 December 2020

Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588.

1 reference

12 December 2020

Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma.

1 reference

12 December 2020

Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: Preclinical experience.

1 reference

12 December 2020

Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells

1 reference

12 December 2020

Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study

1 reference

12 December 2020

Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation

1 reference

12 December 2020

c-Abl tyrosine kinase and inhibition by the cancer drug imatinib (Gleevec/STI-571).

1 reference

12 December 2020

Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.

1 reference

12 December 2020

Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.

1 reference

12 December 2020

Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays.

1 reference

12 December 2020

Characterization of an imatinib-sensitive subset of high-grade human glioma cultures

1 reference

12 December 2020

Second line chemotherapy with docetaxel in patients with recurrent malignant glioma: a phase II study.

1 reference

12 December 2020

Coexpression of stem cell factor and its receptor c-Kit in human malignant glioma cell lines.

1 reference

12 December 2020

Applying the discovery of the Philadelphia chromosome

1 reference

12 December 2020

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

12 December 2020

Oligodendrocyte-type 2 astrocyte progenitors use a metalloendoprotease to spread and migrate on CNS myelin

1 reference

12 December 2020

Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.

1 reference

12 December 2020

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

12 December 2020

Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion.

1 reference

12 December 2020

Genetic pathways to glioblastoma: a population-based study

1 reference

12 December 2020

Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance

1 reference

12 December 2020

Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.

1 reference

12 December 2020

Analysis of Bcr-Abl kinase domain mutations in Korean chronic myeloid leukaemia patients: poor clinical outcome of P-loop and T315I mutation is disease phase dependent

1 reference

12 December 2020

Kinase domain mutations of BCR-ABL identified at diagnosis before imatinib-based therapy are associated with progression in patients with high Sokal risk chronic phase chronic myeloid leukemia.

1 reference

12 December 2020

ERBB receptors and cancer: the complexity of targeted inhibitors

1 reference

12 December 2020

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis

1 reference

12 December 2020

Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein

1 reference

12 December 2020

Neoadjuvant imatinib for unresectable gastrointestinal stromal tumor.

1 reference

12 December 2020

Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec® ) across the mouse blood-brain barrier

1 reference

12 December 2020

Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells

1 reference

12 December 2020

1 reference

12 December 2020

Platelet-derived growth factor in human glioma

1 reference

12 December 2020

Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense

1 reference

12 December 2020

Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies

1 reference

12 December 2020

Akt signaling regulates side population cell phenotype via Bcrp1 translocation.

1 reference

12 December 2020

Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops

1 reference

12 December 2020

Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy

1 reference

12 December 2020

Paclitaxel: a pharmacoeconomic review of its use in non-small cell lung cancer

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

10.1007/S11060-010-0246-1

Identifiers

DOI

1 reference

14 September 2017

1 reference